Sente Cyspera Intensive System


The Cyspera® Intensive System™ is formulated with a proprietary Cysteamine Isobionic-Amide Complex™, a patented and powerful melanosomal transfer inhibitor that is part of the vitamin B3 family, which along with cysteamine, provides three powerful synergistic effects for improved pigment correction and skin health.  The three-product system includes:


Cyspera® Intensive™: features Cysteamine Isobionic-Amid Complex™ that delivers a powerful antioxidant activity to improve the appearance of persistent brown patches and dark spots. This product features a dual chamber technology to keep the cysteamine and AHA separate until skin application. Once applied, the immediate reaction of Isobionic-Amide with AHA leads to instant pigment lightening in the corneal layer.


Cyspera® Neutralize™: features AHA-Amino Acid Complex which neutralizes the smell of cysteamine and re-balances the epidermis before application of Cyspera® Boost™. The L-Arginine Complex stops the Isobionic-Amid Complex™ AHA reaction, and the mild-surfactant gently removes lingering residue, while helping soothe skin and promoting healthy skin barrier. The Lactobionic Acid prepares the skin for Cyspera® Boost™ by neutralizing and balancing the skin’s pH.


Cyspera® Boost™: features Isobionic-Amide Complex™ which works synergistically with Cyspera® Intensive™ to even skin tone, improve complexion and deliver a natural and healthy glow. The Isobionic-Amide acts as a multiplier for the efficacy of cysteamine which inhibits multiple steps in the melanogenesis in the skin. The retinol and an anti-oxidative complex provide a visual pigment correction effect by increasing non-pigmented skin layers and shedding. Lastly, the combination of Isobionic-Amide with retinol provides an anti-inflammatory effect to the skin after application of Cyspera® Intensive™.

Additional Information



According to independent clinical studies, the Cyspera® Intensive System™ delivers evening of skin tone as early as four weeks as proven in clinical studies, including 42% improvement from baseline in pigment correction.